Medicare Enrolled
Dr. Warren Hitt, M.D.
Urology Physician · Panama City, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Hitt from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hitt?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Hitt
Dr. Warren Hitt is an urology physician in Panama City, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Hitt performed 34,055 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Hitt received a total of $9,252 from 52 pharmaceutical and/or device companies across 452 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Hitt is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 4% volume in FL
$9,252 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 48523 | Clear | January 31, 2027 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗34,055
Medicare services
Top 4% in FL for urology physician
Not available
Unique patients (not deduplicated)
$11
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Testosterone undecanoate injection (Aveed) An injection of testosterone undecanoate, a form of testosterone hormone. This procedure involves administering the medication via injection. |
15,750 | $1 | $3 |
| Denosumab injection (Prolia/Xgeva) | 4,440 | $18 | $42 |
| Injection, degarelix, 1 mg | 3,200 | $3 | $8 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
2,600 | $0 | $1 |
| Urinalysis with microscopic exam A urine test performed manually that includes examining the sample under a microscope to check for abnormalities. |
1,948 | $3 | $7 |
| BCG treatment for bladder cancer | 1,800 | $2 | $5 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
987 | $92 | $320 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
708 | $6 | $6 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
697 | $65 | $227 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
286 | $47 | $159 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
282 | $8 | $26 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
210 | $11 | $35 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
193 | $119 | $422 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 158 | $133 | $336 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
134 | $176 | $610 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
89 | $38 | $142 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
75 | $2 | $5 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
64 | $24 | $81 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
60 | $46 | $156 |
| Abdominal X-ray, 2 views An X-ray imaging test of the abdomen using two different angles to visualize internal structures. |
56 | $26 | $73 |
| CT scan of abdomen and pelvis, without contrast A computed tomography scan that creates detailed images of the abdominal and pelvic organs. The procedure is performed without the use of intravenous contrast dye. |
54 | $149 | $379 |
| Insertion of temporary bladder tube | 53 | $35 | $114 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
39 | $68 | $219 |
| Blood creatinine level test A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function. |
32 | $5 | $10 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
23 | $60 | $193 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
23 | $78 | $283 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
22 | $174 | $612 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
22 | $106 | $343 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
20 | $17 | $57 |
| CT scan of abdomen and pelvis with contrast A CT scan of the abdomen and pelvis using contrast dye before and after administration to visualize internal structures. |
17 | $269 | $713 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
13 | $79 | $217 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$9,252
Total received (2018-2024)
Avg $1,322/year across 7 years
Top 22% in FL for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
52
Companies
452
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,281
2023
$1,606
2022
$1,984
2021
$1,674
2020
$812
2019
$1,032
2018
$864
Payments by company (2024)
Dendreon Pharmaceuticals LLC
$204
Astellas Pharma US Inc
$200
Sumitomo Pharma America, Inc.
$143
Endo Pharmaceuticals Inc.
$93
Blue Earth Diagnostics Limited
$81
Endo USA, Inc.
$72
Merck Sharp & Dohme LLC
$66
ABBVIE INC.
$65
Novartis Pharmaceuticals Corporation
$52
Laborie Medical Technologies Corp.
$48
Janssen Biotech, Inc.
$43
AstraZeneca Pharmaceuticals LP
$39
Bayer Healthcare Pharmaceuticals Inc.
$38
PROCEPT BioRobotics Corporation
$30
UROGEN PHARMA, INC.
$23
Teleflex LLC
$19
Medtronic, Inc.
$19
PROGENICS PHARMACEUTICALS, INC.
$18
PFIZER INC.
$15
COLOPLAST CORP
$14
Top 3 companies account for 42.7% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$2,315
Medtronic, Inc.
$1,144
Dendreon Pharmaceuticals LLC
$560
Janssen Biotech, Inc.
$502
PFIZER INC.
$429
Myriad Genetic Laboratories, Inc.
$351
Amgen Inc.
$338
ABBVIE INC.
$286
Endo Pharmaceuticals Inc.
$278
Coloplast Corp
$257
Sumitomo Pharma America, Inc.
$250
UroGen Pharma, Inc.
$198
Bayer HealthCare Pharmaceuticals Inc.
$194
AstraZeneca Pharmaceuticals LP
$164
UROVANT SCIENCES INC
$145
Merck Sharp & Dohme LLC
$139
UROGEN PHARMA, INC.
$124
Rochester Medical Corporation
$121
Blue Earth Diagnostics Limited
$99
Allergan, Inc.
$98
Antares Pharma, Inc.
$96
AbbVie, Inc.
$95
C. R. Bard, Inc. & Subsidiaries
$94
Progenics Pharmaceuticals, Inc.
$75
Endo USA, Inc.
$72
Bayer Healthcare Pharmaceuticals Inc.
$69
TOLMAR Pharmaceuticals, Inc.
$67
COLOPLAST CORP
$66
Novartis Pharmaceuticals Corporation
$65
Foundation Medicine, Inc.
$64
AbbVie Inc.
$49
Laborie Medical Technologies Corp.
$48
180 Medical, Inc.
$41
Axonics, Inc.
$37
Boston Scientific Corporation
$31
PROCEPT BioRobotics Corporation
$30
Cook Medical LLC
$30
ROCHESTER MEDICAL CORPORATION
$26
NeoTract Inc.
$22
Clarus Therapeutics Inc.
$20
Teleflex LLC
$19
PROGENICS PHARMACEUTICALS, INC.
$18
Olympus America Inc.
$17
EDAP TECHNOMED INC
$16
BOSTON SCIENTIFIC CORPORATION
$14
Tolmar, Inc.
$13
Mission Pharmacal Company
$13
Allergan Inc.
$11
MEDIVATION FIELD SOLUTIONS LLC
$11
Ferring Pharmaceuticals Inc.
$11
Retrophin, Inc.
$11
Janssen Pharmaceuticals, Inc
$9
Top 3 companies account for 43.4% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · ADVANTAGE FIT · AQUABEAM SYSTEM · AVYCAZ · Androgel · Axumin · BOTOX · Bulkamid · Coloplast TFL Drive · Cook Medical Lasers · Cook Medical NGage · EDEX · ELIGARD · ERLEADA · EndoSheath Technology · Erleada · FIRMAGON · FOUNDATIONONE · GEMTESA · GentleCath · INTERSTIM · JATENZO · JELMYTO · KEYTRUDA · LUPRON DEPOT · LYNPARZA · LYNX · Lupron · Lupron Depot · MAGIC3 · MYCAMINE · MYRBETRIQ · Myrbetriq · NOCDURNA · Nubeqa · ORGOVYX · OTREXUP · PLUVICTO · POSLUMA · PROLARIS · PROVENGE · PYLARIFY · Padcev · Prolaris · Prolia · SKYLITE · SWISS LITHOCLAST · SpeediCath · TITAN · TOVIAZ · Titan · UROLIFT · Urgent PC Neuromodulation System · Uribel · UroLift · VESICARE · Veozah · XGEVA · XIAFLEX · XTANDI · Xofigo · Xtandi · ZYTIGA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Urology physicians in nearby ZIP areas
9
County median income
$70,188
Nearest hospital to ZIP centroid (approximate)
HCA FLORIDA GULF COAST HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Hitt is a mixed practice specialist, with above-average Medicare volume (top 4% in FL), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Hitt experienced with testosterone undecanoate injection (aveed)?
Based on Medicare claims data, Dr. Hitt performed 15,750 testosterone undecanoate injection (aveed) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Hitt receive payments from pharmaceutical companies?
Yes. Dr. Hitt received a total of $9,252 from 52 companies across 452 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hitt's costs compare to other urology physicians in Panama City?
Dr. Hitt's average Medicare payment per service is $11. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hitt) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Panama City
Browse urology physicians in Panama City ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in FL
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in FL
Which FL urology physicians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc.
By company
Dendreon Pharmaceuticals LLC Payments to Doctors
See all physicians who received payments from Dendreon Pharmaceuticals LLC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology